Literature DB >> 8071476

Hypozincemia in depression.

M Maes1, P C D'Haese, S Scharpé, P D'Hondt, P Cosyns, M E De Broe.   

Abstract

This study investigates serum levels of zinc in 48 unipolar depressed subjects (16 minor, 14 simple major and 18 melancholic subjects) and 32 normal volunteers, and the relationships between zincemia and plasma neopterin levels, postdexamethasone adrenocorticotropic hormone and cortisol values, and anorexia-weight loss. Serum zinc levels were significantly lower in major depressed subjects than in normal controls, whereas minor depressed subjects showed intermediate values. There were significant negative correlations between serum zinc, and severity of depression and plasma neopterin concentrations. No significant relationships between zincemia and either postdexamethasone hormone values or anorexia/weight loss were found. The findings suggest that hypozincemia in major depression may be related to activation of cell-mediated immunity in that illness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071476     DOI: 10.1016/0165-0327(94)90117-1

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  41 in total

1.  Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.

Authors:  M Maes; R Verkerk; E Vandoolaeghe; F Van Hunsel; H Neels; A Wauters; P Demedts; S Scharpé
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Zinc and fatty acids in depression.

Authors:  Gisela Irmisch; Detlef Schlaefke; Joerg Richter
Journal:  Neurochem Res       Date:  2010-06-04       Impact factor: 3.996

3.  Total and ionized calcium and magnesium are significantly lowered in drug-naïve depressed patients: effects of antidepressants and associations with immune activation.

Authors:  Arafat Hussein Al-Dujaili; Hussein Kadhem Al-Hakeim; Ahmed Jasim Twayej; Michael Maes
Journal:  Metab Brain Dis       Date:  2019-07-10       Impact factor: 3.584

Review 4.  Nutrition and depression: implications for improving mental health among childbearing-aged women.

Authors:  Lisa M Bodnar; Katherine L Wisner
Journal:  Biol Psychiatry       Date:  2005-07-25       Impact factor: 13.382

5.  Oral zinc augmentation with vitamins A and D increases plasma zinc concentration: implications for burden of disease.

Authors:  F C V Potocnik; S J van Rensburg; D Hon; R A Emsley; I M Moodie; R T Erasmus
Journal:  Metab Brain Dis       Date:  2006-08-02       Impact factor: 3.584

6.  Low dietary or supplemental zinc is associated with depression symptoms among women, but not men, in a population-based epidemiological survey.

Authors:  Nancy N Maserejian; Susan A Hall; John B McKinlay
Journal:  J Affect Disord       Date:  2011-10-24       Impact factor: 4.839

Review 7.  Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury.

Authors:  Brandon P Lucke-Wold; Aric F Logsdon; Linda Nguyen; Ahmed Eltanahay; Ryan C Turner; Patrick Bonasso; Chelsea Knotts; Adam Moeck; Joseph C Maroon; Julian E Bailes; Charles L Rosen
Journal:  Nutr Neurosci       Date:  2016-10-05       Impact factor: 4.994

8.  Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.

Authors:  Andreas M Grabrucker; Magali Rowan; Craig C Garner
Journal:  Drug Deliv Lett       Date:  2011-09

9.  Zinc transporters protein level in postmortem brain of depressed subjects and suicide victims.

Authors:  Anna Rafalo-Ulinska; Joanna Piotrowska; Agata Kryczyk; Włodzimierz Opoka; Magdalena Sowa-Kucma; Paulina Misztak; Grazyna Rajkowska; Craig A Stockmeier; Wojciech Datka; Gabriel Nowak; Bernadeta Szewczyk
Journal:  J Psychiatr Res       Date:  2016-09-13       Impact factor: 4.791

10.  Antidepressant-like activity of zinc: further behavioral and molecular evidence.

Authors:  Magdalena Sowa-Kućma; Beata Legutko; Bernadeta Szewczyk; Kinga Novak; Paweł Znojek; Ewa Poleszak; Mariusz Papp; Andrzej Pilc; Gabriel Nowak
Journal:  J Neural Transm (Vienna)       Date:  2008-09-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.